Gynaecologic Oncology

Division Head:
Dr. Allan Covens
Staff, Sunnybrook Health Sciences Centre
Professor, Department of Obstetrics & Gynaecology, University of Toronto 
Tel: (416) 480-4378
Email: al.covens@sunnybrook.ca

 

Staff

Fellowship Program

Research Activitites

Grants

Publications

Presentations

Honours

Welcome to the Gynaecologic Oncology Division at the University of Toronto!

The Gynaecologic Oncology program includes 5 hospitals:  Sunnybrook Health Sciences Centre (SHSC), Princess Margaret Hospital (PMH)/University Health Network (UHN)/Mount Sinai Hospital (MSH), Trillium Health Partners (THP), and Women's College Hospital (WCH). Our staff now comprises of 13 gynaecologic oncologists: 5 at Sunnybrook, 5 at Princess Margaret Hospital, and 3 at the Trillium Health Parthers. In addition to providing patient care at their sites, the SHSC and PMH gynaecologic oncologists perform colposcopies at WCH. This is the largest group of gynaecologic oncologists in Canada and one of the most clinically active groups in North America.

Gynaecologic oncology supports medical student, resident, and fellow education. All University of Toronto residents spend a month in our division as a PGY 1 and 3 months as a PGY3 or 4. The Fellowship program is the largest and the only 3-year training program in Canada. It includes 2 years of clinical training along with 1 year of research, with two fellows in each year. 

The gynaecologic oncology program is very committed to research. SHSC and PMH both have very robust research programs. Over the last two years this group has used an endowed fund, The McArthur Fund, to promote collaborative research between the two groups. Research supported by this fund includes sentinel node studies in endometrial cancer and the GOC 2 study where economic and clinical outcomes are being compared between robotic, laparoscopic, and open surgery for endometrial cancer. Other studies receiving this support are conducted in endometrial cancer and vulvar melanoma.

The Division of Gynaecologic Oncology has also become committed to an international (global) health initiative in Kenya. Several members of the division have travelled to Kenya to provide education and training to gynaecologists in Eldoret - an initiative part of the University of Toronto AMPATH program. This program is also very active in reaserach and has a Grand Challenges Canada Grant, as well as grants from National Institute of Health and Centers for Disease Control and Presention.

Staff

The Gynaecologic Oncology program includes 5 hospitals:  Sunnybrook Health Sciences Centre (SHSC), Princess Margaret Hospital (PMH)/University Health Network (UHN)/Mount Sinai Hospital (MSH), Trillium Health Partners (THP), and Women's College Hospital (WCH). Our staff now comprises of 13 gynaecologic oncologists: 5 at Sunnybrook, 5 at Princess Margaret Hospital, and 3 at the Trillium Health Parthers. In addition to providing patient care at their sites, the SHSC and PMH gynaecologic oncologists perform colposcopies at WCH. This is the largest group of gynaecologic oncologists in Canada and one of the most clinically active groups in North America.

Staff at Sunnybrook Health Sciences Centre 

Dr. Allan Covens is head of Gynaecologic Oncology at Sunnybrook Health Sciences Centre. the principal investigator at the Odette Cancer Center for the NRG Oncology Group, and co-chairs the Rare Tumour Committee. He is also the co-Chair of the cervical cancer task force for the NCI (US). Dr. Rachel Kupets has recently been appointed as the lead scientist for Ontario Cervical Screening Program. Dr. Lilian Gien has recently been appointed the junior Principal Investigator for the Sunitinib arm of the National Cancer Institute MATCH trial. She continues to evaluate and publish data from the Vulvar Cancer Grant. She is also evaluating factors predictive for outcome in phase II trials for recurrent and advanced cervical cancer as part of her Young Investigator Award from the Gynecologic Oncology Group. Dr. Danielle Vicus has successfully been awarded peer-reviewed grants for two investigator-initiated trials: oral iron therapy to reduce the likelihood of homologous blood transfusions, and a study evaluating Anal Intraepithelial Neoplasia in women with history of cervical cancer or high grade dysplasia. Dr. Ray Osborne is the Co-Principal Investigator on a large multi-center randomized study in low-risk gestational trophoblastic neoplasia.

Staff at University Health Network 

Dr. Marcus Bernardini is the Head of Gynaecologic Oncology at the University Health Network. Dr. Stephane Laframboise is the fellowship director for the University of Toronto Gynaecologic Oncology Fellowship, and the site group leader in gynaecologic oncology at Princess Margaret Hospital and is the Fellowship coordinator for the UHN site. Dr. Sarah Ferguson is also the Principle Investigator for the NCIC “Shape” trial that will compare radical to simple hysterectomy for small stage 1b cervical cancers. Dr. Taymaa May, who joined the PMH group in September of 2013 after completing her fellowship in Boston at Harvard, is working on establishing collaborations to conduct basic science research. She is already working closely with Dr. Theodore Brown at the Lunenfeld-Tanenbaum Research Institute. Dr. Genevieve Bouchard-Fortier, who recently completed her fellowship with the department, joins PMH as of July, 2016.

The PMH group has a very robust program in hereditary breast and ovarian cancer, which is focused on identifying BRCA germline mutation carriers and providing them with strategies for cancer prevention. Dr. Sarah Ferguson leads the group’s initiative in survivorship, which has become a very important part of cancer care at all cancer centres. She is conducting several studies and is part of several research projects including two where she is the PI.  She is also the PI on studies investigation Lynch syndrome and endometrial cancer. 

Staff at Trillium Health Partners 

Dr. Joan Murphy is the Program Chief and Medical Director of Women and Children's Health at Trillium Health Partners. Dr. Tomer Feigenberg joined the Division in December, 2013, and has taken a staff position at Trillium Health Partners. He completed his fellowship in 2013 at the University of Toronto and has an appointment as an Assistant Professor in Obstetrics and Gynaecology. Another recent grad from the fellowship program, Dr. Kate Pulman, rounds out the THP team as of July, 2016.
 

Fellowship Program

For complete information about the Gynaecologic Oncology/RCPSC program, click here.

This program is currently a 2-year clinical fellowship combined with a mandatory third year focused on providing each fellow with formal training and/or experience in an academic (non-clinical) field relevant to their future career in Gynaecologic Oncology.  
 

Research Activities

Coming soon!

Grants

Coming soon!

Publications

Coming soon!

Presentations

Coming soon!

Honours

Coming soon!

Back to Top